BioCentury | Feb 25, 2021
Deals
Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen, AmacaThera, and more
...Management and existing investors Atlas Venture, SV Health Investors, Takeda Ventures, RiverVest Venture Partners and MRL Ventures Fund.Diagnostics...